Thalidomide downregulates transcript levels of GC-rich promoter genes in multiple myeloma.

被引：0
|
作者：
Uziel, O
Shapira, A
Radnay, J
Lahav, M
Lishner, M
机构：
[1] Sapir Med Ctr, Oncogenet Lab, Kefar Sava, Israel
[2] Sapir Med Ctr, Hematol Lab, Kefar Sava, Israel
[3] Sapir Med Ctr, Dept Med, Kefar Sava, Israel
[4] Tel Aviv Univ, IL-69978 Tel Aviv, Israel
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1573
引用
收藏
页码：373A / 374A
页数：2
相关论文
共 50 条
  • [1] Thalidomide down-regulates transcript levels of GC-rich promoter genes in multiple myeloma
    Drucker, L
    Uziel, O
    Tohami, T
    Shapiro, H
    Radnay, J
    Yarkoni, S
    Lahav, M
    Lishner, M
    MOLECULAR PHARMACOLOGY, 2003, 64 (02) : 415 - 420
  • [2] Thalidomide in IgA multiple myeloma.
    Lim, SH
    Maclean, R
    BLOOD, 1998, 92 (10) : 279B - 279B
  • [3] Thalidomide with dexamethasone for resistant multiple myeloma.
    Weber, DM
    Rankin, K
    Gavino, M
    Delasalle, K
    Alexanian, R
    BLOOD, 2000, 96 (11) : 167A - 167A
  • [4] Thalidomide alone or with dexamethasone for multiple myeloma.
    Weber, DM
    Gavino, M
    Delasalle, K
    Rankin, K
    Giralt, S
    Alexanian, R
    BLOOD, 1999, 94 (10) : 604A - 604A
  • [5] Immunoreactivity of thalidomide in patients with multiple myeloma.
    Luo, SK
    Li, J
    Hong, WD
    Zhou, ZH
    BLOOD, 2002, 100 (11) : 367B - 367B
  • [6] Oral melphalan, prednisone and thalidomide for multiple myeloma.
    Palumbo, A
    Bringhen, S
    Musto, P
    Caravita, T
    Capozzi, R
    Callea, V
    Cangialosi, C
    Montanaro, M
    Catalano, L
    Grasso, M
    Petti, MC
    Merla, M
    Falchi, L
    Omedè, P
    Ceccarelli, M
    Ambrosini, MT
    Avonto, I
    Gay, F
    Falco, P
    Boccadoro, M
    BLOOD, 2005, 106 (11) : 230A - 230A
  • [7] Thalidomide and dexamethasone combination for refractory multiple myeloma.
    Galani, E
    Grigoraki, V
    Kiamouris, C
    Samantas, E
    Economou, O
    Papdimitriou, C
    Gika, D
    Anagnostopoulos, N
    Dimopoulos, M
    ANNALS OF ONCOLOGY, 2000, 11 : 96 - 96
  • [8] Low dose thalidomide for the treatment of multiple myeloma.
    Bittencourt, R
    Almeida, AD
    Friederich, JR
    Fernande, F
    Fogliatto, L
    Paz, A
    Astigarraga, C
    Leugeur, D
    Silla, L
    BLOOD, 2005, 106 (11) : 370B - 370B
  • [9] Impact of thalidomide on survival of patients with multiple myeloma.
    Fawaz, A
    Magro, L
    Leleu, X
    Depil, S
    Guillerm, G
    Corm, S
    Bauters, F
    Facon, T
    Yakoub-Agha, I
    BLOOD, 2002, 100 (11) : 384B - 384B
  • [10] Thalidomide and dexamethasone in newly diagnosed multiple myeloma.
    McHugh, J
    Keane, C
    Otridge, BW
    Thornton, P
    O'Gorman, P
    BLOOD, 2005, 106 (11) : 380B - 380B
12345